
Über diesen Podcast
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support…
298 Folgen · Wissenschaft
PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
Über diesen Podcast
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support…
Neue Folgen
- Jamie Carroll, APRN, CNP, MSN - Staying Ahead of the ADC Curve Across Solid Tumors: Empowering Advanced Practice Providers to Navigate Current and Emerging Options12. Nov. · 1 Std. 05 Min.
- Sagar Lonial, MD, FACP / Krina Patel, MD, MSc - Re-Booting Modern Treatment for Relapsed/Refractory Myeloma: Innovative Therapeutics and Implications for Patient Care6. Nov. · 1 Std. 01 Min.
- Michelle Kittleson, MD, PhD - The Evolving ATTR-CA Landscape: From Recognition to Disease-Modifying Therapy28. Okt. · 56 Min.
- Thomas Martin, MD / Amrita Krishnan, MD, FACP - Personalizing Multiple Myeloma Care: Evidence and Guideline-Informed Application of Current Treatment Options23. Okt. · 1 Std. 23 Min.
- Reynold A. Panettieri, Jr., MD - Stepping Up to Success in Uncontrolled Asthma: Implementing Triple Therapy to Reduce Exacerbations and Optimize Control23. Okt. · 27 Min.
- Prof. David Planchard, MD, PhD - From Data to Decisions in HER2-Overexpressing NSCLC: Detecting Alterations, Implementing Therapeutic Advances, and Navigating Practicalities of Care9. Okt. · 59 Min.
- Stephen V. Liu, MD - Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes9. Okt. · 58 Min.
- Pam R. Taub, MD, FACC, FASPC - Managing ASCVD From the Inside Out: Comprehensive Strategies for Getting the Most From Innovative Lipid-Lowering Therapies5. Okt. · 52 Min.
- William G. Wierda, MD, PhD - C3–Changing Conversations on CLL: Evidence and Emerging Consensus on Targeted Agents Across Lines of Therapy5. Okt. · 1 Std. 02 Min.
- Mario Castro, MD - Strategies for Incorporating Biologic Therapy Into Individualized COPD Treatment Plans28. Sept. · 24 Min.